Interactions of Polymyxin B in Combination with Aztreonam, Minocycline, Meropenem, and Rifampin against Escherichia coli Producing NDM and OXA-48-Group Carbapenemases

Carbapenemase-producing Enterobacterales pose an increasing medical threat. Combination therapy is often used for severe infections; however, there is little evidence supporting the optimal selection of drugs. This study aimed to determine the in vitro effects of polymyxin B combinations against car...

Descripción completa

Detalles Bibliográficos
Autores principales: Olsson, Anna, Hong, Marcus, Al-Farsi, Hissa, Giske, Christian G., Lagerbäck, Pernilla, Tängdén, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597741/
https://www.ncbi.nlm.nih.gov/pubmed/34516251
http://dx.doi.org/10.1128/AAC.01065-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597741/
https://www.ncbi.nlm.nih.gov/pubmed/34516251
http://dx.doi.org/10.1128/AAC.01065-21

Ejemplares similares